Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|November 3, 2025
Multiplex engineering and multifunction T cells for precise and effective immunotherapiesLeila Jafarzadeh, Ali Smaani, Jean-Sébastien Delisle
Iranian Journal of Immunology : IJI|December 27, 2012
Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy lossBehrouz Gharesi-Fard, Leila Jafarzadeh, Jaleh Zolghadri, et al.
Critical Reviews in Oncology/Hematology|December 2, 2020
Biomarkers for predicting the outcome of various cancer immunotherapiesLeila Jafarzadeh, Mohammad Khakpoor-Koosheh, Hamed Mirzaei, et al.
Journal of Medical Signals and Sensors|September 19, 2022
Predicting Efficacy of 5-Fluorouracil Therapy via a Mathematical Model with Fuzzy Uncertain ParametersSajad Shafiekhani, Amir Homayoun Jafari, Leila Jafarzadeh, et al.
Frontiers in Immunology|May 12, 2020
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways ForwardLeila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 30, 2012
Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patientsBehrouz Gharesi-Fard, Leila Jafarzadeh, Farzaneh Ghaderi-shabankareh, et al.
Human Cell|May 28, 2024
Aquaporins in colorectal cancer: exploring their role in tumorigenesis, metastasis, and drug responseMaryam Azimi Mohammadabadi, Ali Moazzeni, Leila Jafarzadeh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 8, 2021
The application of immune checkpoint blockade in breast cancer and the emerging role of nanoparticleElham Masoumi, Sahar Tahaghoghi-Hajghorbani, Leila Jafarzadeh, et al.
The Journal of Obstetrics and Gynaecology Research|April 21, 2022
Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspectsLeila Jafarzadeh, Maryam Ranjbar, Tina Nazari, et al.
Journal of Translational Medicine|November 28, 2021
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitroKhadijeh Alishah, Matthias Birtel, Elham Masoumi, et al.
Pageof 2